Kodiak Sciences, Inc. (KOD)

32.71 -0.14 (-0.43%) USD  |  NASDAQ  |  Sep 18, 16:00
32.70 -0.01 (-0.03%) After-Hours: 20:00
More

Kodiak Sciences Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for KOD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Revenue Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
September 17, 2026 --
August 26, 2026 --
August 17, 2026 --
August 14, 2026 --
August 03, 2026 --
July 31, 2026 --
July 30, 2026 --
May 12, 2026 --
May 11, 2026 --
May 08, 2026 --
April 02, 2026 --
April 01, 2026 --
March 27, 2026 --
March 26, 2026 --
February 12, 2026 --
January 22, 2026 --
November 17, 2025 --
November 14, 2025 --
November 11, 2025 --
Date Value
September 22, 2025 --
August 18, 2025 --
August 16, 2025 --
August 14, 2025 --
July 17, 2025 --
July 10, 2025 --
May 22, 2025 --
May 19, 2025 --
May 15, 2025 --
April 09, 2025 --
April 08, 2025 --
March 31, 2025 --
March 28, 2025 --
September 05, 2024 --
August 17, 2024 --
August 15, 2024 --
August 14, 2024 --
May 16, 2024 --
April 10, 2024 --

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade
Savara, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade